Article
Clinically relevant genotype interpretation of resistance to didanosine.
Antimicrobial agents and chemotherapy - 1 May 2005
Marcelin Anne-Geneviève, Flandre Philippe, Pavie Juliette, Schmidely Nathalie, Wirden Marc, Lada Olivier, Chiche Dan, Molina Jean-Michel, Calvez Vincent
Abstract excerpt
We analyzed the didanosine (ddI) arm of the randomized, placebo-controlled Jaguar trial in order to define a genotypic score for ddI associated with virologic response. In this arm, 111 patients experiencing virologic failure received ddI in addition to their current combination therapy for 4 weeks. The impact of mutations in the reverse transcriptase gene on the virologic response to ddI was studied in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
